ARTICLE

FindCenter AddIcon

The Cost of Exclusion in Psychedelic Research

By Xinyuan Chen, Mackenzie Bullard, Christy Duan, Jamilah R. George, Terence Ching, Stephanie Kilpatrick, Jordan Sloshower, Monnica Williams — 2020

In the last two decades, researchers have started to reexamine psychedelics for their therapeutic potential. Though initial results seem promising, the research has a significant shortcoming: the lack of racial and ethnic diversity among research teams and study participants.

Read on blog.petrieflom.law.harvard.edu

FindCenter Post-Image

Ketamine Therapy Is Going Mainstream. Are We Ready?

The mind-altering drug has been shown to help people suffering from anxiety and depression. But how it helps, who it will serve, and who will profit are open questions.

Article
Emily Witt
2021
FindCenter AddIcon
FindCenter Post-Image

Can Ketamine Treat Depression? the Answer May Lie in a Mysterious Brain Cell

To treat depression, the neurons which control the hormones serotonin and dopamine in our brains seem to get all the attention.

Article
Sophie Putka
2021
FindCenter AddIcon
FindCenter Post-Image

Two Men Share Their Experience with Treatment for PTSD

This is a story about two very different men, their fight with post-traumatic stress disorder, and their coping options.

Article
Lewis Turner
2021
FindCenter AddIcon

EXPLORE TOPIC

Psychedelic Research